In the work reported here, we found that overexpression of SORBS1 inhibited the activation of JNK and the downstream molecule c-Jun, but had no effect on ERK or p38 signaling in breast cancer or lung cancer cells. The gene discussed is SORBS1; the disease is breast cancer.